Bace1 Inhibitory Antibodies

The present invention relates to antibodies with a specificity for BACE1. More specifically, the invention provides monoclonal antibodies which bind to BACE1 and are capable of inhibiting the activity of BACE1 and methods producing these antibodies. Said antibodies can be used for research and medical applications. Specific applications include the use of BACE1 specific antibodies for the treatment of Alzheimer's disease.

Patents:
WO 2,010,146,058

Inventor(s): DE STROOPER BART [BE]; ZHOU LUJIA [BE]; ANNAERT WIM [BE]

Type of Offer: Sale



« More Medical Patents

---